AFP and hepatocellular carcinoma: Products in development for HCC surveillance include multi-analyte tests with diagnostic algorithms that analyze cfDNA methylation in plasma, AFP, AFP-L3, and DCP levels in serum and patient age and sex to provide a qualitative screening result (58,59,67,68).